Related Experiment Video

Updated: Jun 4, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

In vitro inhibition of feline coronavirus replication by small interfering RNAs

Phillip McDonagh1, Paul A Sheehy, Jacqueline M Norris

  • 1Faculty of Veterinary Science, Building B14, The University of Sydney, Sydney, NSW 2006, Australia.

Veterinary Microbiology
|March 4, 2011
PubMed

Insights

Small interfering RNA (siRNA) effectively inhibits feline coronavirus (FCoV) replication, offering a potential new treatment for feline infectious peritonitis (FIP). This RNA interference (RNAi) approach shows promise for FIP therapy.

Area of Science:

  • Veterinary Virology
  • Molecular Biology
  • Immunology

Background:

  • Feline infectious peritonitis (FIP) is a fatal immune-mediated disease caused by virulent feline coronavirus (FCoV).
  • Current treatments for FIP lack effective antiviral options.

Purpose of the Study:

  • To evaluate the efficacy of small interfering RNA (siRNA) mediated RNA interference (RNAi) in inhibiting FCoV replication.
  • To identify potent siRNAs for potential therapeutic application against FIP.

Main Methods:

  • Testing eight synthetic siRNAs targeting different FCoV genome regions in an immortalized feline cell line.
  • Assessing antiviral effects using qRT-PCR, TCID50 infectivity assays, and immunofluorescence assays (IFA).

Main Results:

  • All tested siRNAs inhibited FCoV replication in vitro.
  • Two siRNAs, targeting the 5' leader sequence (L2) and nucleocapsid gene (N1), reduced extracellular virus by over 95%.
  • These effective siRNAs demonstrated efficacy at low concentrations and high viral loads.

Conclusions:

  • RNA interference (RNAi) using specific siRNAs is a viable strategy to inhibit FCoV replication.
  • These findings support the potential therapeutic use of RNAi for treating FIP in cats.

More Related Videos

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation07:53

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on: January 9, 2019

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis09:35

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis

Published on: August 9, 2013

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...